<qa>  What is the purpose of this clinical research study?The goal of this clinical research study is to learn if ruxolitinib or dasatinib in combination with chemotherapy can help to control Philadelphia Chromosome Ph-like acute lymphoblastic leukemia ALL. The safety of these drug combinations will also be studied. 